Clinical Trials Directory

Trials / Unknown

UnknownNCT02074865

Children's Antibiotic Resistant Infections in Low Income Countries

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Institut Pasteur · Industry
Sex
All
Age
1 Minute – 3 Days
Healthy volunteers
Accepted

Summary

The main challenge of the ChARLI program is to assess the clinical burden of severe neonatal and childhood bacterial infections in low-income countries,in particular those caused by antibiotic resistant bacteria. This program will address both healthcare associated, as well as community acquired infections. Beside its main challenge, the ChARLI program will also allow the assessment of the economic burden of these infections, the improvement of their medical care and then ultimately help to set public health interventions and guide public health measures necessary to combat bacterial infections and bacterial resistance in children. It will also lead to set up more basic research investigation to better understand how pathogenic and epidemic may be the resistant clones in these countries and to experiment innovative strategies devoted to prevent these infections. In order to achieve these objectives, an international paediatric cohort will be created, and monitored a platform. This will be done first within the Institut Pasteur International Network (IPIN) and possibly extended in some others low income countries where the IPIN has no center. This constituted initiative will represent the first international pediatric program of its size to be located in low-income countries and specifically focusing severe bacterial infections and bacterial resistance to antibiotics

Conditions

Interventions

TypeNameDescription
BIOLOGICALbiological samples

Timeline

Start date
2012-09-01
Primary completion
2014-03-01
First posted
2014-02-28
Last updated
2014-02-28

Locations

1 site across 1 country: Madagascar

Source: ClinicalTrials.gov record NCT02074865. Inclusion in this directory is not an endorsement.